Biohaven Ltd. (BHVN)
(Delayed Data from NYSE)
$37.94 USD
-0.51 (-1.33%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $37.93 -0.01 (-0.03%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth C Momentum F VGM
Brokerage Reports
0 items in cart
Biohaven Ltd. [BHVN]
Reports for Purchase
Showing records 221 - 240 ( 271 total )
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Biotechnology-Neurology Prescription Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Script Data Continues To Appear Solid, Raising Target to $94
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Working For The Weekend - Highlights From Virtual AHS Meeting
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Biotechnology: Neurology Prescription Sales Tracker -- Week Ending 6/5/20
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Neurology Prescription Sales Tracker - Week Ending 5/29/20
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Neurology Prescription Sales Tracker - Week Ending 5/8/20
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Prevention Filing Advancing, Launch Unfolding - All Cylinders Firing
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Neurology Prescription Sales Tracker -- Week Ending 4/10/20
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Neurology Prescription Sales Tracker -- Week Ending 4/03/20
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Biotechnology - Neurology Prescription Sales Tracker -- Week Ending 3/27/20
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Long-Awaited Prevention Trial Arrives, Meets Endpoint
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
We See Prevention As Approvable; Takeaways From Management Call
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
COVID-19 and Clinical Trials: A Combo That Doesn''t Mix?
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Neurology Prescription Sales Tracker -- Week Ending 3/13/20
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Neurology Prescription Sales Tracker - Week Ending 3/13/20
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L